Stories about Fermentation

Subscribe to Fermentation

22.09.2020 – 15:30

Jennewein Biotechnologie GmbH
Jennewein Biotechnologie GmbH and Chr. Hansen A/S to join forces in high-growth Human Milk Oligosaccharides market

Rheinbreitbach and Bonn, Germany (ots/PRNewswire) - Jennewein Biotechnologie GmbH agreed to join forces with Chr. Hansen Holding A/S, a leading bioscience company based in Hoersholm/Denmark, to lead the global market for human milk oligosaccharides (HMOs). Chr. Hansen entered into an agreement to acquire all shares ...

more
22.09.2020 – 15:30

Jennewein Biotechnologie GmbH
Jennewein Biotechnologie GmbH and Chr. Hansen A/S to join forces in high-growth Human Milk Oligosaccharides market

Rheinbreitbach/Bonn (ots) - Jennewein Biotechnologie GmbH agreed to join forces with Chr. Hansen Holding A/S, a leading bioscience company based in Hoersholm/Denmark, to lead the global market for human milk oligosaccharides (HMOs). Chr. Hansen entered into an agreement to acquire all shares in Jennewein ...

more
20.08.2020 – 16:21

Jennewein Biotechnologie GmbH
US Customs rules in favor of Jennewein Biotechnologie regarding importation of 2'-Fucosyllactose

RHEINBREITBACH, Germany (ots) - Jennewein Biotechnologie GmbH the leading manufacturer of human milk oligosaccharides (HMOs) in the world, announced today that the Intellectual Property Rights Branch, Regulations and Rulings, U.S. Customs and Border Protection issued a Ruling Letter which asserts that the HMO 2'-fucosyllactose (2'-FL) being produced by Jennewein ...

more
29.07.2020 – 15:00

Jennewein Biotechnologie GmbH
Jennewein Biotechnologie GmbH announces the foundation of Jennewein Biotech Corp. USA

Rheinbreitbach (ots) - Jennewein Biotechnologie GmbH, a market leading and science-based company for developing and producing human milk oligosaccharides (HMOs) and rare monosaccharides, announced today that it has established its subsidiary in the USA. Jennewein Biotech USA Corporation, a Delaware Corporation, utilizing warehouses in Chicago, IL and Columbus, OH, will ...

more
29.06.2020 – 14:01

Brenntag AG
Brenntag Food & Nutrition opens new Application & Development Center in Brazil

Dear all, Please find attached the press release of Brenntag Food & Nutrition regarding the opening its newest Food Application & Development Center (FADC) in Guarulhos, close to Sao Paulo in Brazil. For further information please see the press release. Please do not hesitate to ...
Brenntag Food & Nutrition website

more
27.05.2020 – 11:00

Jennewein Biotechnologie GmbH
Jennewein publishes new results on the norovirus-inhibiting effect of complex oligosaccharides

Rheinbreitbach (ots) - Jennewein Biotechnologie GmbH today announces the publication of the latest results from its norovirus research program in the Journal of Biotechnology. Breast-fed infants are less likely than bottle-fed infants to contract norovirus infections, and earlier work has indicated a link between this protective effect and human milk oligosaccharides ...

more
20.05.2020 – 15:09

Jennewein Biotechnologie GmbH
Supply of Key Ingredient in advanced infant formula by Jennewein is secured

Rheinbreitbach (ots) - Jennewein Biotechnologie GmbH, a worldwide leading manufacturer of human milk oligosaccharides (HMOs) announces today that the U.S. International Trade Commission (ITC) issued on May 19, 2020 a Final Determination finding that one of Jennewein's advanced bacterial production strains for producing 2'-fucosyllactose (2'-FL) does not infringe ...

more
10.01.2020 – 12:00

Jennewein Biotechnologie GmbH
Jennewein Biotechnologie GmbH enforces its patents in the field of human milk oligosaccharides against Nestlé in Germany

Rheinbreitbach (ots) - Jennewein Biotechnologie GmbH filed a patent infringement suit with the regional court in Mannheim on January 09, 2020 against Nestlé Nutrition GmbH and its holding company Nestlé Deutschland AG. Nestlé offers its infant formula Beba Supreme which contains two human milk oligosaccharides - ...

more
08.01.2020 – 17:00

Jennewein Biotechnologie GmbH
Publication of a toxicological study: a milestone for Jennewein Biotechnologie for the GRAS approval of the HMO-mix

Rheinbreitbach (ots) - Jennewein Biotechnology announces another milestone in the Worldwide approval of a new product generation, the "HMO-Mix". The data of the toxicological study, with the title "A Safety Evaluation of Mixed Human Milk Oligosaccharides in Rats", was recently accepted for publication by the ...

more
25.11.2019 – 12:29

AGRANA Beteiligungs-AG
EANS-News: ? 100 million investment: AGRANA opens second wheat starch plant at site in Pischelsdorf (Lower Austria) - IMAGE

http://resources.euroadhoc.com/images/2118/5/10381423/AGRANA_Banddurchschneidung_Pischelsdorf.jpg issuer: AGRANA Beteiligungs-AG F.-W.-Raiffeisen-Platz 1 A-1020 Wien phone: +43-1-21137-0 FAX: +43-1-21137-12926 mail: info.ab@agrana.com WWW: www.agrana.com ISIN: AT000AGRANA3 indexes: WBI stockmarkets: Berlin, ...

more
25.11.2019 – 10:13

Jennewein Biotechnologie GmbH
Jennewein Biotechnologie obtains US-FDA GRAS status on alternative 2'-fucosyllactose fermentation strain

Rheinbreitbach (ots) - Jennewein Biotechnologie GmbH, Rheinbreitbach, the leading manufacturer of human milk oligosaccharides (HMOs), announces that the U.S. Food and Drug Administration (FDA) issued a "no question" response letter to Jennewein's supplement of its GRAS Notice GRN571, thereby acknowledging that the ...

more
25.11.2019 – 10:02

Jennewein Biotechnologie GmbH
Jennewein Biotechnologie sues Glycom for patent infringement in Denmark

Rheinbreitbach (ots) - Jennewein Biotechnologie develops fermentative processes for manufacturing of human milk oligosaccharides (HMOs) cost efficiently in an industrial scale since 2005 to make these special sugars available for affordably priced infant formula and other uses in food. Jennewein Biotechnologie was the first commercial vendor of HMOs, and brought the ...

more
18.09.2019 – 11:04

Brenntag AG
Brenntag and Corbion strengthen their partnership in EMEA

Dear all, Please find attached Brenntag's press release regarding the signing of an enhanced framework agreement with Corbion, strengthening the companies' long-time partnership in the EMEA region. For further information please see the press release. Please do not hesitate to contact us if you have further questions. Best regards, ...
Find more information on our website.

more
11.09.2019 – 17:00

Jennewein Biotechnologie GmbH
Administrative Law Judge issues ruling in patent dispute concerning 2'-FL production and beta-galactosidase activity

Rheinbreitbach (ots) - On September 09, 2019, Administrative Law Judge Cameron Elliot of the US International Trade Commission issued an Initial Determination finding that one of the bacterial strains used by Jennewein Biotechnologie to make 2'-fucosyllactose (2'-FL) infringes a patent owned by Glycosyn LLC. In the ...

more
27.02.2019 – 09:18

nova-Institut GmbH

PRESS RELEASE (DE/EN): The "Top 6" candidates are nominated for the first innovation award "Best CO2 Utilisation 2019"

Subscribe to nova's mailing list

more
20.02.2019 – 19:02

Novasep
Novasep Announces the Success of Its Consent Solicitation Extending the Maturity of Its Notes

Lyon, France (ots/PRNewswire) - - All resolutions were approved by 100% of the participating Noteholders and C Warrantholders - Noteholders representing 99.9% of total outstanding principal amount participated Novasep Holding S.A.S ("Novasep"), a leading supplier of services and technologies for the life sciences industry, is pleased to announce that the consent ...

more
05.02.2019 – 10:00

Jennewein Biotechnologie GmbH
Jennewein Biotechnologie and Yili Group join forces in China for microbiome research and human milk oligosaccharides to bring innovation to the largest baby food market

Hohhot, China & Rheinbreitbach, Germany (ots) - - China represents the largest market for baby food globally - Human milk oligosaccharides are key for the development of a healthy infant microbiome Jennewein Biotechnologie GmbH, the global leader in the research and manufacture of human milk oligosaccharides (HMO), ...

more
31.01.2019 – 16:34

Novasep
Novasep Announces the Launch of a Consent Solicitation for the Maturity Extension of Notes with Requisite Voting Majority of the Noteholders Already Secured

Lyon, France (ots/PRNewswire) - Novasep Holding S.A.S ("Novasep"), a leading supplier of services and technologies for the life sciences industry, announces the launch of a consent solicitation (the "Consent Solicitation") in order to, inter alia : - extend the maturity of the senior notes in an initial aggregate ...

more
08.10.2018 – 14:00

Jennewein Biotechnologie GmbH
Jennewein Biotechnologie GmbH acquires Arthus Mineralsprings Bad Hönningen to build a new integrated fermentation and recovery plant for human milk oligosaccharides

Rheinbreitbach/Germany (ots) - Jennewein Biotechnologie GmbH announces that it has acquired the former facilities of Arthus Mineralspring Company in Bad Hönningen (Rhineland-Palatine) in order to expand the production of human milk oligosaccharides (HMOs). "We have been searching for some time for a suitable ...

more
05.07.2018 – 12:00

Jennewein Biotechnologie GmbH
Jennewein Biotechnologie to build new R&D centre for synthetic organisms and microbiome research in Bonn, Germany

Rheinbreitbach (ots) - Jennewein Biotechnologie announces that on June 15, 2018, it signed a long-term lease for a 1000-m2 plot of land on Mildred-Scheel-Straße, Bonn Bad Godesberg, which will be the site of a new R&D centre for microbiome research and designer microorganisms. "The relocation of part of our ...

more

1